New Oral Drug Approved for Herpes Lesions
(MedPage Today) -- The FDA approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) infections in immunocompromised patients who haven't responded to other treatments. Pritelivir, an oral helicase...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.